Recombinant multi-species HOXB9 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine HOXB9 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene is a member of the Abd-B homeobox family and encodes a protein with a homeobox DNA-binding domain. It is included in a cluster of homeobox B genes located on chromosome 17. The encoded nuclear protein functions as a sequence-specific transcription factor that is involved in cell proliferation and differentiation. Increased expression of this gene is associated with some cases of leukemia, prostate cancer and lung cancer. [provided by RefSeq, Jul 2008]
The Alternative Names of target: HOX-2.5,HOX2,HOX2E,HOXB9,Homeobox protein Hox-2.5,Homeobox protein Hox-2E,Homeobox protein Hox-B9,Hox-2.5,Hoxb9

Target products collectionGo to HOXB9 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP8005-Ag-1/ GM-Tg-hg-IP8005-Ag-2 Human HOXB9 protein Human
GM-Tg-rg-IP8005-Ag-1/ GM-Tg-rg-IP8005-Ag-2 Rat HOXB9 protein Rat
GM-Tg-mg-IP8005-Ag-1/ GM-Tg-mg-IP8005-Ag-2 Mouse HOXB9 protein Mouse
GM-Tg-cynog-IP8005-Ag-1/ GM-Tg-cynog-IP8005-Ag-2 Cynomolgus/Rhesus macaque HOXB9 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP8005-Ag-1/ GM-Tg-felg-IP8005-Ag-2 Feline HOXB9 protein Feline
GM-Tg-cang-IP8005-Ag-1/ GM-Tg-cang-IP8005-Ag-2 Canine HOXB9 protein Canine
GM-Tg-bovg-IP8005-Ag-1/ GM-Tg-bovg-IP8005-Ag-2 Bovine HOXB9 protein Bovine
GM-Tg-equg-IP8005-Ag-1/ GM-Tg-equg-IP8005-Ag-2 Equine HOXB9 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP8005-Ag-1/ GM-Tg-hg-IP8005-Ag-2; GM-Tg-rg-IP8005-Ag-1/ GM-Tg-rg-IP8005-Ag-2;
GM-Tg-mg-IP8005-Ag-1/ GM-Tg-mg-IP8005-Ag-2; GM-Tg-cynog-IP8005-Ag-1/ GM-Tg-cynog-IP8005-Ag-2;
GM-Tg-felg-IP8005-Ag-1/ GM-Tg-felg-IP8005-Ag-2; GM-Tg-cang-IP8005-Ag-1/ GM-Tg-cang-IP8005-Ag-2;
GM-Tg-bovg-IP8005-Ag-1/ GM-Tg-bovg-IP8005-Ag-2; GM-Tg-equg-IP8005-Ag-1/ GM-Tg-equg-IP8005-Ag-2
Products Name HOXB9 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name HOXB9
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine HOXB9 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.